Nerve Growth Factor in Pediatric Brain Injury: From Bench to Bedside
<b>Background:</b> Traumatic brain injury (TBI) and hypoxic–ischemic encephalopathy (HIE) are major causes of long-term neurological disability in children, with limited options for effective neuronal recovery. Recent research has highlighted the therapeutic potential of nerve growth fac...
Saved in:
| Main Authors: | Lorenzo Di Sarno, Serena Ferretti, Lavinia Capossela, Antonio Gatto, Valeria Pansini, Anya Caroselli, Luigi Manni, Marzia Soligo, Antonio Chiaretti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal Human-Recombinant Nerve Growth Factor Enhances Motor and Cognitive Function Recovery in a Child with Severe Traumatic Brain Injury
by: Lorenzo Di Sarno, et al.
Published: (2025-01-01) -
Vagus nerve stimulation ameliorates cognitive impairment caused by hypoxia
by: Birendra Sharma, et al.
Published: (2025-06-01) -
Dimeric dipeptide mimetic the 1st loop of nerve growth factor of GK-6, which activates PI3K/AKT and MEK/MAPK/ERK, causes a neuronal type differentiation of PC12 cells
by: T. A. Antipova, et al.
Published: (2017-11-01) -
A study on the mnemotropic and antidepressant-like effects of the low-molecular-weight mimetic of nerve growth factor, dipeptide GK-2, in experimental ischemic stroke
by: P. Yu. Povarnina, et al.
Published: (2024-06-01) -
Bench to Bedside : diagnostic microbiology for the clinicians /
Published: (2018)